secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2023-05-15T23:59:59+00:00
Accession:  0001493152-23-017322
Event type: debt
Sentiment:  negative
Materiality: 0.65
Item codes: 1.01, 2.03, 2.04, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma defaults on $125K convertible note; enters $5M equity facility
--------------------------------------------------------------------------------

- Entered equity line facility for up to $5M over 36 months; shares sold at 80% of lowest VWAP.
- Issued $125K 10% convertible note with $25K OID; $12.5K guaranteed interest; due in 7 monthly payments from March 24, 2023.
- Company in default as of March 24, 2023 for failure to make payments and reverse split without consent; discussions to cure.
- Warrant holder exercised $150K of Series B warrants; terms extended to March 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315223017322/0001493152-23-017322-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315223017322/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-017322

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer